Showing results (41-50 of 937) with videos related to

Sort By:
Pageof 94
Global Public Health|October 18, 2016
Mobilising a global response to hepatitis: Lessons learned from the HIV movementJessica Taaffe, David Wilson
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 14, 2014
Who pays and why? Costs, effectiveness, and feasibility of HIV treatment as preventionDavid Wilson, Nicole Fraser
Journal of Child and Adolescent Psychopharmacology|September 13, 2013
Attention-deficit/hyperactivity disorder drugs and growth: an Italian prospective observational studyElena A P Germinario, Romano Arcieri, Maurizio Bonati, et al.
Igiene E Sanita Pubblica|July 23, 2003
[DREAM project early results (drug resources enhancement against AIDS in Mozambique)]Maria Cristina Marazzi, Leonardo Palombi, Leonardo Emberti Gialloreti, et al.
HIV Clinical Trials|July 11, 2007
Simplified maintenance therapy with abacavir/lamivudine/zidovudine plus tenofovir after sustained HIV load suppression: four years of follow-upGabriella d'Ettorre, Lorenzo Zaffiri, Giancarlo Ceccarelli, et al.
Journal of Child and Adolescent Psychopharmacology|January 31, 2013
Cardiovascular measures in children and adolescents with attention-deficit/hyperactivity disorder who are new users of methylphenidate and atomoxetineRomano Arcieri, Elena A P Germinario, Maurizio Bonati, et al.
AIDS (London, England)|December 4, 2004
Causes of death in HIV infection: the key determinant to define the clinical response to anti-HIV therapyAmanda Mocroft, Jose Gatell, Peter Reiss, et al.
Pageof 94